These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8172384

  • 1. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
    Wahl DG, Simon JP, Robin B, Walker P, Jouanny P, Escanye JM, Paille F, Schmidt C, Brunotte F, Robert J.
    Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
    [Abstract] [Full Text] [Related]

  • 2. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.
    Greiner A, Esterhammer R, Messner H, Biebl M, Mühlthaler H, Fraedrich G, Jaschke WR, Schocke MF.
    J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693
    [Abstract] [Full Text] [Related]

  • 3. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH, Brinkmann G, Förger K, Gleim M, Wunsch-Binder F, Maier C, Zick G.
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [Abstract] [Full Text] [Related]

  • 4. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs.
    Keller U, Oberhänsli R, Huber P, Widmer LK, Aue WP, Hassink RI, Müller S, Seelig J.
    Eur J Clin Invest; 1985 Dec; 15(6):382-8. PubMed ID: 3938408
    [Abstract] [Full Text] [Related]

  • 5. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
    Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD.
    J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
    [Abstract] [Full Text] [Related]

  • 6. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 7. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: effects of vascular therapy on spectroscopic results.
    Schunk K, Romaneehsen B, Rieker O, Düber C, Kersjes W, Schadmand-Fischer S, Schmiedt W, Thelen M.
    Invest Radiol; 1998 Jun 23; 33(6):329-35. PubMed ID: 9647444
    [Abstract] [Full Text] [Related]

  • 8. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy.
    Hands LJ, Bore PJ, Galloway G, Morris PJ, Radda GK.
    Clin Sci (Lond); 1986 Sep 23; 71(3):283-90. PubMed ID: 3757432
    [Abstract] [Full Text] [Related]

  • 9. High-energy phosphate metabolism in the calf muscle during moderate isotonic exercise under different degrees of cuff compression: a phosphorus 31 magnetic resonance spectroscopy study.
    Greiner A, Esterhammer R, Pilav S, Arnold W, Santner W, Neuhauser B, Fraedrich G, Jaschke WR, Schocke MF.
    J Vasc Surg; 2005 Aug 23; 42(2):259-67. PubMed ID: 16102624
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo.
    Kemp GJ, Roberts N, Bimson WE, Bakran A, Harris PL, Gilling-Smith GL, Brennan J, Rankin A, Frostick SP.
    J Vasc Surg; 2001 Dec 23; 34(6):1103-10. PubMed ID: 11743568
    [Abstract] [Full Text] [Related]

  • 11. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy.
    Kemp GJ, Hands LJ, Ramaswami G, Taylor DJ, Nicolaides A, Amato A, Radda GK.
    Clin Sci (Lond); 1995 Dec 23; 89(6):581-90. PubMed ID: 8549076
    [Abstract] [Full Text] [Related]

  • 12. [Phosphorus-31 NMR spectrometry of the calf muscles in patients with arterial claudication. Preliminary results].
    Le Bas JF, Reutenauer H, Franco A, Magne JL, Benabid AL.
    J Mal Vasc; 1987 Dec 23; 12(1):70-7. PubMed ID: 3559414
    [Abstract] [Full Text] [Related]

  • 13. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease. Correlation with clinical and angiographic findings and comparison with healthy volunteers.
    Schunk K, Romaneehsen B, Mildenberger P, Kersjes W, Schadmand-Fischer S, Thelen M.
    Invest Radiol; 1997 Nov 23; 32(11):651-9. PubMed ID: 9387051
    [Abstract] [Full Text] [Related]

  • 14. Skeletal muscle metabolism in the leg during exercise in patients with congestive heart failure.
    Marie PY, Escanye JM, Brunotte F, Robin B, Walker P, Zannad F, Robert J, Gilgenkrantz JM.
    Clin Sci (Lond); 1990 May 23; 78(5):515-9. PubMed ID: 2162280
    [Abstract] [Full Text] [Related]

  • 15. [Dynamic 31-phosphorus magnetic resonance spectroscopy of the m. quadriceps: therapy-induced changes in arterial occlusive disease].
    Schunk K, Romaneehsen B, Dahm M, Dietz U, Kersjes W, Schadmand-Fischer S, Düber C, Thelen M.
    Rofo; 1997 Aug 23; 167(2):139-46. PubMed ID: 9333354
    [Abstract] [Full Text] [Related]

  • 16. 31P in-vivo spectroscopic study by high-field whole-body MR system--an application to a case with arteriosclerosis obliterans.
    Nishimura T, Imakita S, Naito H, Takamiya M, Matsuo H, Nakayama R.
    Angiology; 1987 Aug 23; 38(8):609-13. PubMed ID: 3631643
    [Abstract] [Full Text] [Related]

  • 17. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle.
    Williams DM, Fencil L, Chenevert TL.
    Radiology; 1990 May 23; 175(2):381-5. PubMed ID: 2326464
    [Abstract] [Full Text] [Related]

  • 18. Medical treatment of peripheral vascular disease: good or bad?
    Duprez D, Clement DL.
    Eur Heart J; 1992 Feb 23; 13(2):149-51. PubMed ID: 1555609
    [Abstract] [Full Text] [Related]

  • 19. [Effects of a nucleotide-nucleoside mixture on ischemic muscle metabolism in patients with stage II peripheral arterial occlusive disease. MR spectroscopic and biochemical analytic results].
    Rexroth W, Huber KH, Rädle J, Semmler W, van Kaick G.
    Vasa; 1994 Feb 23; 23(2):98-108. PubMed ID: 8036845
    [Abstract] [Full Text] [Related]

  • 20. Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study.
    Taylor DJ, Amato A, Hands LJ, Kemp GJ, Ramaswami G, Nicolaides A, Radda GK.
    Vasc Med; 1996 Feb 23; 1(4):241-5. PubMed ID: 9552578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.